Ticker Symbol: NXTC
Nextcure Inc
$6.05 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001661059
Company Profile
NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through its proprietary FIND-IO™ platform, NextCure studies various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Its initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 9000 Virginia Manor Rd Ste 200
Website: www.nextcure.com
CEO: Michael Richman
Tags:
- Biotechnology
- Health Technology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.32
Change:
$0.04
(
3.12%)
Days Range: $1.23 - $1.34
Beta: 0.82
52wk. High: $2.66
52wk. Low: $1.15
Ytd. Change -6.09%
50 Day Moving Average: $1.34
200 Day Moving Average: $1.58
Shares Outstanding: 27839968
Valuation
Market Cap: 3.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A